QWK-86259-40903
4 vaccinations
3 coded responses
33 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 752 / TX
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-31
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Registered in v-safe
-
2021-02-20
Dose 2 — Pfizer-BioNTech
- 2021-02-20
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-05-22
- 2021-08-21
-
2021-11-05
Dose 3 — Pfizer-BioNTech
- 2021-11-05
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-11
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
-
2022-02-04
Survey response — 3 months, dose 3MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Sore throat, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-05-07
-
2022-09-20
Dose 4 — Pfizer-BioNTech
-
2022-11-07
Survey response — 12 months, dose 3MedDRA: Cough, Discharge, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion, upper respiratory drainage, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-11-07
Survey response — day 42, dose 4MedDRA: Cough, Discharge, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion, upper respiratory drainage, coughMedDRA releases: 2024-11 · check-in free text available
- 2022-12-20
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-31 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-20 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 3
Symptoms: Sore throat, runny nose
Release 12 — 12 months, dose 3
Symptoms: Congestion, upper respiratory drainage, cough
Release 12 — day 42, dose 4
Symptoms: Congestion, upper respiratory drainage, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Discharge | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release